Literature DB >> 2836871

The influence of calcium channel blockers on superoxide anions.

F Shridi1, J Robak.   

Abstract

Four calcium channel blockers were tested from the point of view of their influence on enzymic lipid oxidation and on generation of superoxide anions. All the compounds were found to be antioxidants as tested by the inhibition of NADPH-stimulated malonaldehyde formation from lipids. IC50 values were 60 microM for nifedipine; 1.1 microM for verapamil; 1.4 microM for fendiline and 20.6 microM for diltiazem. Only nifedipine scavenged superoxide anions both in an enzymic (xanthine:xanthine oxidase) and non-enzymic (phenazine methosulphate:NADH) generating system. IC50 values for this inhibition were about 2.5 times higher than for inhibition of formation of malonaldehyde. Nifedipine inhibited also xanthine oxidase-mediated formation of uric acid.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2836871     DOI: 10.1016/s0031-6989(88)80603-9

Source DB:  PubMed          Journal:  Pharmacol Res Commun        ISSN: 0031-6989


  4 in total

1.  Effects of benidipine hydrochloride on antioxidant enzyme activity in stroke-prone spontaneous hypertensive rats (SHR-SP).

Authors:  I Shou; L N Wang; Y Takahashi; M Fukui; Y Tomino
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

2.  Beneficial effects of felodipine on myocardial and coronary function during low-flow ischemia and reperfusion.

Authors:  E A Bernstein; F R Eberli; A M Silverman; G L Horowitz; C S Apstein
Journal:  Cardiovasc Drugs Ther       Date:  1996-05       Impact factor: 3.727

3.  The effect of selected antiarrhythmic drugs on neutrophil free oxygen radicals production measured by chemiluminescence.

Authors:  T Siminiak; H Wysocki; A Veit; H R Maurer
Journal:  Basic Res Cardiol       Date:  1991 Jul-Aug       Impact factor: 17.165

Review 4.  Calcium antagonists and stunned myocardium: importance for clinicians?

Authors:  K Przyklenk; R A Kloner
Journal:  Cardiovasc Drugs Ther       Date:  1991-10       Impact factor: 3.727

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.